IncFact
Company Profiles: Revenue, Growth, Competition

Kovina Therapeutics Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Kovina Therapeutics

Access the complete profile.

Kovina Therapeutics Fast Facts

RevenueN/A    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry N/A
Address1210 Waterway Blvd Ste 2000
Indianapolis, IN 46202

Note: Revenues for privately held companies are statistical evaluations.


Kovina Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Kovina Therapeutics is classified as operating in the N/A industry, NAICS Code .


Investor Activity

Kovina Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
July 14, 2021 11 80%$3 MM
Complete list of funding rounds and total amounts in the Company Report




Nearby Competitors

These companies are similar in business line and location to Kovina Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ELEVANCE HEALTHIndianapolis, IN100 
ATH HOLDINGIndianapolis, IN71 
ELI LILLYIndianapolis, IN20 
HERITAGE GROUPIndianapolis, IN14 
ASPHALT MATERIALSIndianapolis, IN14 
CORTEVAIndianapolis, IN10 




Other Companies at 1210 Waterway Blvd Ste 2000, Indianapolis IN

Company HeadquartersRevenue ($ MM)
INDIANA BIOSCIENCES RESEARCH INSTITUTEIndianapolis, IN100 
ADIPO THERAPEUTICSIndianapolis, IN0 
EARLY IS GOODIndianapolis, IN0 


(0.1075 s)



Future Competition: Kovina Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Kovina Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Kovina Therapeutics Competitors